First 10 drugs for Medicare price negotiation may see minimal commercial impact
The Biden Administration has released the highly anticipated list of 10 drugs selected for Medicare price negotiations under the US…
The Biden Administration has released the highly anticipated list of 10 drugs selected for Medicare price negotiations under the US…
The Biden Administration has released the highly anticipated list of ten drugs selected for Medicare price negotiations under the Inflation…
This article is produced as part of GlobalData’s Price Intelligence (POLI) service, the world’s leading resource for global pharmaceutical pricing,…
Biosimilars for AbbVie’s (US) Humira (adalimumab) have finally launched in the US, bringing an end to Humira’s 20-year reign as…
Although the US midterm elections have not fully concluded, it is now known who has control of each chamber of…
For its latest high-profile review, the US Institute for Clinical and Economic Review (ICER) concluded that the three COVID-19 pills…